Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Orio

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Clinical Genitourinary Cancer|December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active SurveillanceDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Cancer|August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Medical Physics|September 4, 2023
Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapyMartin T King, Christopher E Kehayias, Tafadzwa Chaunzwa, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Brachytherapy|August 17, 2016
Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancerYu-Wei Chen, Vinayak Muralidhar, Brandon A Mahal, et al.
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
BMC Urology|February 9, 2024
Prostate cancer presentation and management in the Middle EastMutlay Sayan, Astrid Langoe, Ozlem Aynaci, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.
The Journal of Urology|February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate CancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Clinical Genitourinary Cancer|December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active SurveillanceDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Cancer|August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Medical Physics|September 4, 2023
Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapyMartin T King, Christopher E Kehayias, Tafadzwa Chaunzwa, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Brachytherapy|August 17, 2016
Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancerYu-Wei Chen, Vinayak Muralidhar, Brandon A Mahal, et al.
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
BMC Urology|February 9, 2024
Prostate cancer presentation and management in the Middle EastMutlay Sayan, Astrid Langoe, Ozlem Aynaci, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.
The Journal of Urology|February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate CancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Pageof 9